3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Classical hematology
1
Conditions
Hematologic Neoplasms
2
Other Infectious Diseases
1
Neutropenia
1
Neoplasms
1
Fever
1
Febrile Neutropenia
1
Interventions
pegfilgrastim
3
liposomal amphotericin B
2
Vancomycin
2
Filgrastim
2
Caspofungin
2
trametinib
1
ofatumumab
1
dabrafenib
1
Teicoplanin
1
Tazobactam
1
Surveys and Questionnaires
1
Ritonavir
1
Quality of Life
1
Povidone-Iodine
1
Piperacillin, Tazobactam Drug Combination
1
Piperacillin
1
Metformin
1
Meropenem
1
Lenalidomide
1
Itraconazole
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Granulocyte Colony-Stimulating Factor
1
Doxorubicin
1
Docetaxel
1
Daptomycin
1
Cyclophosphamide
1
Cloxacillin
1
Cilastatin, Imipenem Drug Combination
1
Ceftazidime
1
Cefepime
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Fever
×
Meropenem
×
Clear all
NCT02149329
2019-09-25
SHORT
Amsterdam UMC, location VUmc
Phase 4
Completed
276 enrolled